Gilead shares jump on hepatits C drug results
November 12, 2012 at 11:53 AM EST
Shares of Gilead Sciences jump after the biotechnology firm announces positive results from a hepatitis C treatment
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.